Filing Details

Accession Number:
0001870913-23-000018
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-11-20 21:05:59
Reporting Period:
2023-11-17
Accepted Time:
2023-11-20 21:05:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1023024 Ani Pharmaceuticals Inc ANIP Pharmaceutical Preparations (2834) 582301143
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1870913 Muthusamy Shanmugam C/O Ani Pharmaceuticals, Inc.
210 Main Street West
Baudette MN 56623
Head Of R&D, Coo-Novitium Ops Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-11-17 13,000 $51.00 982,620 No 4 S Indirect Held by Esjay LLC
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect Held by Esjay LLC
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 47,407 Direct
Common Stock 5,000 Indirect Held by SS Pharma LLC
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $50.70 to $51.43, inclusive.
  3. The reporting person holds voting and dispositive power over the shares held by Esjay LLC.
  4. The Reporting Person holds voting and dispositive power over the shares held by SS Pharma LLC.